Boston Scientific Endoscopy

Our customer-centric approach encompasses staff training, infection prevention education, online ordering and scope repair services through a strategic partner to enhance patient care and make it easier to do business with Boston Scientific: https://bit.ly/3PRhqhM #Endoscopy

Boston Scientific is thrilled to sponsor The 8th #SASMBS Annual Conference?taking place 7-9 February 2025 at Movenpick Al Khobar, Kingdom of Saudi Arabia. This is a fantastic opportunity to empower HCPs in field of endoscopy through education, professional growth, and leadership development, with a special focus on EndoBariatric skills. Don’t miss our Pre-congress?Hands on Endobariatrics Workshop on 7th Feb from 8:00 am to 18 :00 pm to learn from experts as they share their experiences showcasing Overstitch?. Join us at the Boston Scientifc booth to discover the opportunities Endobariatrics can bring to your practice Learn more about the program here: https://lnkd.in/e8Jc_z2x #Endobariatrics ?#BSCEMEA #sasmbs?

The 27th INTERNATIONAL ENDOSCOPY SYMPOSIUM in Düsseldorf is just a few days away! We look forward to an engaging event filled with insightful discussions and inspiring interactions. This year, we have an exciting program lined up for you: ?? Cholangioscopy Symposium on Thursday, February 6th – Mark your calendars! ?? Innovation Talks on Friday, February 7th – Be sure to join us! Visit us at booth # 05. We look forward to meeting you in person and exchanging ideas! #BSCEMEA #Endoscopy #Cholangioscopy #EndoDusseldoft

Dr. James Buxbaum, an advanced endoscopist at the USC Keck School of Medicine, explains a randomized trial he conducted comparing cholangioscopy-guided laser lithotripsy and conventional therapy for large bile duct stones–a study that showed more than 90% of participants undergoing the cholangioscopy-guided approach demonstrating clearance. To learn more, visit: https://bit.ly/4gxBSzf Dr. James Buxbaum is a paid consultant of Boston Scientific. #Endoscopy

NEW Medicare Code for Defect Closure Procedures Boston Scientific is committed to advancing the field of endoscopy. Recently, the Centers for Medicare and Medicaid Services approved our application for a new HCPCS code describing endoscopic defect closure procedures for complication management such as leaks, perforations and fistulas within the GI tract. Effective July 1, 2024 hospitals may use C9901 to report defect closure procedures in the outpatient setting. The 2024 Medicare national average hospital outpatient payment for C9901 is $9,808, increasing 6% to $10,411 in 2025. Defect closure procedures may include devices that are part of Boston Scientific’s portfolio including the MANTIS? Clip, OverStitch? NXT and X-Tack? Endoscopic Suturing Systems. I am so proud of our Health Economics and Market Access team’s long history of successful advocacy to support patient access. References 1. Centers for Medicare and Medicaid Services. July 2024 Update of the Hospital Prospective Payment System (OPPS) R12665CP. https://lnkd.in/eFpibhAS ? All Health economic and reimbursement information provided by Boston Scientific Corporation is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules, and policies. This information is presented for illustrative purposes only and does not constitute reimbursement, coverage, coding, or legal advice. Boston Scientific encourages providers to submit accurate and appropriate claims for services. It is always the provider’s responsibility to determine medical necessity, the proper site for delivery of any services, and to submit appropriate codes, charges, and modifiers for services rendered. It is also always the provider’s responsibility to understand and comply with Medicare national coverage determinations (NCD), Medicare local coverage determinations (LCD), and any other coverage requirements established by relevant payers which can be updated frequently. Boston Scientific recommends that you consult with your payers, reimbursement specialists, and/or legal counsel regarding coding, coverage, and reimbursement matters. Boston Scientific does not promote the use of its products outside their FDA-approved label. Information included herein is current as of July 1, 2024, but is subject to change without notice. Rates for services are effective July 1, 2024. ? All trademarks are the property of their respective owners. CAUTION: The law restricts these devices to sale by or on the order of a physician. Indications, contraindications, warnings and instructions for use can be found at apolloendo.com/dfus or at www.IFU-BSCI.com. ? 2024 Copyright ? Boston Scientific Corporation or its affiliates. All rights reserved. ENDO-1997114-AA

Our Technique Spotlight features Dr. Sumit Singla, an advanced endoscopist at Henry Ford Health, detailing his experience performing an endoscopic retrograde cholangiopancreatography (ERCP) with plastic stent placement—including his use of the EXALT? Model D single-use duodenoscope. To learn more, visit: https://bit.ly/3UVwZb4 Dr. Sumit Singla is a paid consultant of Boston Scientific. #Endoscopy

Last week, we wrapped up another SpyGlass Masters Course at the Institute for Advancing Science in the UK! Our goal is to empower healthcare professionals from the UK and Ireland with the confidence to perform complex endoscopic procedures. Looking to enhance your skills or expand your expertise? Don't miss out on the opportunity to join our future courses. Follow us or reach out to your local representative to learn more. #BSCEMEA #EDUCARE

In a recent episode of the GI EndoCast, USC Keck School of Medicine advanced endoscopist Dr. Jennifer Phan describes how she utilizes the SpyGlass? DS II Direct Visualization System. Listen to the full episode to hear how she works with the SpyGlass? technology when patients present with larger stones or stones proximal to a stricture: https://bit.ly/4ebpPXZ Dr. Jennifer Phan is a paid consultant of Boston Scientific. #Endoscopy #ESG #Fluoroscopy

When faced with a fork in the road, is it possible to take both paths? It is during ERCP – using the double-wire technique to separate the bile duct path from the pancreatic duct path. Hear how Dr. Sammy Ho explains his approach to achieving biliary access while mitigating risk, then explore more techniques at: https://bit.ly/3ArCDdw #Endoscopy #BiliaryAccess #ERCP

“This is the right technology at the right time and an exciting step forward in weight loss for patients.” Read in The Wall Street Journal how the Apollo ESG? System helps patients lose weight by reducing their stomach size without any incisions or scars – and why some say it represents the future of GI procedures.?https://lnkd.in/gkPvVeaV